Clover Health partners with Kno2 for real-time patient data access in federal interoperability initiatives, enhancing care coordination.
Quiver AI Summary
Clover Health Investments, Corp. and Kno2 announced a collaboration that enhances Clover Health's participation in federal interoperability initiatives aimed at improving data exchange in healthcare. This partnership allows Clover Health to respond to patient requests for clinical and claims data in real time, utilizing standardized formats from the Centers for Medicare & Medicaid Services (CMS). The collaboration emphasizes the importance of seamless data exchange, particularly for Medicare patients with complex health needs, enabling coordinated care across various treatment settings. Powered by Counterpart Health, Clover's technology ensures structured data is accurately exchanged, setting a precedent for other payers in the industry. The companies will showcase their interoperability capabilities at the HIMSS 2026 conference.
Potential Positives
- Clover Health's collaboration with Kno2 positions it as a leader in facilitating real-time, interoperable data exchange, enhancing the patient experience and aligning with national healthcare initiatives.
- The integration of Clover Assistant with Counterpart Health allows for efficient data processing, demonstrating the company's commitment to value-based care and improved health outcomes.
- Clover Health's participation in interoperability efforts may attract attention from health plans looking to enhance their capabilities, potentially leading to new business opportunities.
Potential Negatives
- The press release's emphasis on the use of new technologies and partnerships may suggest a response to previous criticisms regarding Clover Health's capabilities in data management and patient care, potentially highlighting past shortcomings.
- The statement that "interoperable data exchange is not aspirational" may imply that previous efforts in this area were inadequate, casting doubt on Clover Health’s past initiatives.
- The requirement for real-time patient access to claims data may raise concerns about Clover Health's existing infrastructure adequacy and readiness to handle such demands effectively.
FAQ
What is Clover Health's recent collaboration about?
Clover Health is collaborating with Kno2 to enhance interoperability in healthcare by enabling real-time data exchanges through a connected network.
How does Clover Health support patient data access?
Clover Health allows patients to securely authenticate and request their clinical and claims data using standardized FHIR formats.
Why is interoperability important for Medicare patients?
Interoperability ensures seamless data exchange as patients transition across care settings, improving coordinated care for those with chronic conditions.
What technology powers Clover Health's interoperability efforts?
The interoperability capabilities are powered by Counterpart Health, which provides the infrastructure for real-time data exchange between payers and providers.
When and where will Clover Health demonstrate its capabilities?
Clover Health will showcase its interoperability solution at HIMSS 2026, from March 10 to 12, at the Kno2 booth #12720.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- BRADY PATRICK PRIEST (CEO of Home Care) sold 175,000 shares for an estimated $379,750
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 7 sales selling 65,437 shares for an estimated $203,718.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLOV Revenue
$CLOV had revenues of $487.7M in Q4 2025. This is an increase of 44.74% from the same period in the prior year.
You can track CLOV financials on Quiver Quantitative's CLOV stock page.
$CLOV Hedge Fund Activity
We have seen 82 institutional investors add shares of $CLOV stock to their portfolio, and 119 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP removed 3,523,047 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,780,523
- RENAISSANCE TECHNOLOGIES LLC removed 3,221,559 shares (-41.8%) from their portfolio in Q4 2025, for an estimated $7,570,663
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 2,768,088 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,505,006
- BLACKROCK, INC. added 1,885,917 shares (+6.2%) to their portfolio in Q4 2025, for an estimated $4,431,904
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,878,719 shares (-70.7%) from their portfolio in Q4 2025, for an estimated $4,414,989
- DIMENSIONAL FUND ADVISORS LP added 1,494,043 shares (+69.8%) to their portfolio in Q4 2025, for an estimated $3,511,001
- JANE STREET GROUP, LLC removed 1,380,091 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $3,243,213
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
$CLOV Price Targets
Multiple analysts have issued price targets for $CLOV recently. We have seen 2 analysts offer price targets for $CLOV in the last 6 months, with a median target of $3.1.
Here are some recent targets:
- Whit Mayo from Leerink Partners set a target price of $2.5 on 03/05/2026
- Richard Close from Canaccord Genuity set a target price of $3.7 on 01/20/2026
Full Release
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of Clover Health's participation in federal interoperability initiatives.
WILMINGTON, Del., March 10, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, and Kno2, healthcare’s leading communication network, today announced a collaboration enabling Clover Health to be live on a network that is participating in interoperability efforts publicly announced by the Centers for Medicare & Medicaid Services (CMS) to drive interoperability goals. Clover is demonstrating that nationwide, interoperable data exchange is not aspirational, it is achievable today.
Through this collaboration, Clover Health now responds in real time to patient-directed requests for clinical and claims data using standardized FHIR (USCDI v3) formats. This activity is consistent with publicly described CMS Health Tech Ecosystem, including the CMS-aligned network concepts and TEFCA’s IAS implementation, enabling patients to securely authenticate and request their health information from any participating payer through a connected network.
As patients move across care settings, seamless data exchange becomes critical. A Medicare patient with multiple chronic conditions may transition between primary care, specialty care, hospital, and home-based services. With standards-based interoperability, care teams remain aligned, enabling proactive, coordinated care within a value-based model.
Clover Health’s participation is powered by Counterpart Health , its technology and services business that enables physicians, payers, and risk-based entities to achieve outsized success in value-based care by leveraging a wide range of clean clinical data at scale. Kno2 securely routes patient-directed requests across the network and Counterpart Health enables the standardized exchange of data. Clover Health then responds as the payer with structured clinical and claims information.
Clover Health’s early participation reflects its support for broader national interoperability efforts and demonstrates how interoperable, patient-directed data exchange can operationalize today. Because the underlying infrastructure is powered by Counterpart Health, similar technical capabilities may be extended to other health plans seeking to participate in interoperability networks.
“Counterpart Assistant was built from the ground up as a bi-directional interoperable platform, already connecting hundreds of data sources. These are not bolt-on capabilities or compliance projects. They are foundational components of how the system operates in production,” said Kevin Holub, Chief Product Officer at Counterpart Health. “When that infrastructure already exists, participating in aligned networks becomes a fast add on benefit, not a build.”
"When our members have secure, real-time access to their clinical and claims information, it enables both transparency and control, including easier sharing with caregivers and providers, and ultimately a deeper understanding of their own health journey," said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “Because of Clover Assistant and the infrastructure we already have in place through Counterpart Health, we are well positioned to meet member needs like this today."
"Clover Health's willingness to enable real-time patient access to claims data, sets the standard for payers everywhere. We're proud to enable this milestone and look forward to expanding into broader interoperability initiatives as CMS and TEFCA have put forth." said Therasa Bell, President & Founder, Kno2.
Clover Health, Kno2, and Counterpart Health will conduct live demonstrations of an end-to-end response to a patient authenticated claims data request March 10 - 12, 2026 throughout HIMSS 2026 in the Aligned Networks Showcase at the Kno2 booth #12720. The demonstration will show a patient request flowing through the network via Kno2, reaching Counterpart Health’s responding gateway, and securely returning structured clinical and claims data from Clover Health’s infrastructure.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale.
Visit:
www.cloverhealth.com
About Counterpart Health:
Counterpart Health
, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on
Diabetes
,
Chronic Kidney Disease
,
Congestive Heart Failure
, and
Chronic Obstructive Pulmonary Disease
management, as well as
Clinical Quality
and
Underserved Patient Populations
.
About Kno2:
Kno2 is leading the future of healthcare communication by providing the nation’s largest comprehensive communication network including as a federally designated Qualified Health Information Network (QHIN) and
CMS Aligned network
. Kno2 enables secure, effortless exchange of patient information across providers, payers, patients, and technology vendors, processing billions of transactions annually.
Media Contacts:
Clover Health: [email protected]